Invention Grant
![3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors](/docs/US/2019-09-24/US10421731B2/abs.jpg.600x600.jpg)
- Patent Title: 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
-
Application No.: US16218126Application Date: 2018-12-12
-
Publication No.: US10421731B2Publication Date: 2019-09-24
- Inventor: Xiaozhang Zheng , Pui Yee Ng , Bingsong Han , Jennifer R. Thomason , Mary-Margaret Zablocki , Cuixian Liu , Aleksandra Rudnitskaya , David R. Lancia, Jr. , David S. Millan , Matthew W. Martin , Kenneth W. Bair
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: Forma Therapeutics, Inc.
- Current Assignee: Forma Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Choate, Hall & Stewart LLP
- Agent John P. Rearick; Cristin E. Juda
- Main IPC: A61K31/5513
- IPC: A61K31/5513 ; C07D243/14 ; C07D267/14 ; C07D413/06 ; C07D413/12 ; C07D413/04 ; C07D291/08 ; C07D401/06 ; C07D401/10 ; C07D403/06 ; C07D403/10 ; C07D405/06 ; C07D413/14 ; C07D417/04 ; C07D471/04 ; C07D498/04 ; C07D498/08 ; C07D493/08 ; C07D413/08 ; C07D491/107 ; C07D495/10 ; C07D267/12
![3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors](/abs-image/US/2019/09/24/US10421731B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I: where R, L, X1, X2, X3, X4, Y1, Y2, Y3, and Y4 are described herein.
Public/Granted literature
- US20190112282A1 3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS Public/Granted day:2019-04-18
Information query
IPC分类:
